Interleukin-31: A new cytokine involved in inflammation of the skin

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 1, 2006, Pages 1-4

  Castellani, M L ^a   Salini, V ^a   Frydas, S ^b   Donelan, J ^c   Madhappan, B ^c   Petrarca, C ^a   Vecchiet, J ^a   Falasca, K ^a   Neri, G ^a   Tete', S ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Dermatitis; IL 31; Inflammation; T cell response

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 31; STAT3 PROTEIN; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ALOPECIA; DERMATITIS; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SKIN DEFECT; SKIN INFLAMMATION; TH2 CELL;

EID: 33646271824     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/205873920601900101     Document Type: Editorial

References (39)

1. th ed. D.P. Stites, A.I. Terr and T.G. Parslow. Appleton and Lange Stamford, Connecticut, p. 146.
2. Abbas A.K., A.H. Lichtman and J.S. Pober. 1991. Cells and tissues of the immune system. In Cellular and Molecular Immunology. A.K. Abbas, ed. W.B. Saunders Company Philadelphia, p. 14.
3. 4 and serum amyloid A elicit opposite interleukin-8 and NF-κB responses via the common ALX receptor. Int. J. Immunopathol. Pharmacol. 17:145.
4. neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in her-2/neu transgenic mice. Int. J. Immunopathol. Pharmacol. 18:351.
5. Kempuraj D., J. Donelan, S. Frydas, T. Iezzi, P. Conti, W. Boucher, N. G. Papadoopoulou, B. Madhappan, L. Letourneau, G. Sabatino and T.C. Theoharides. 2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol. 17:103.
6. Kempuraj D., S. Frydas, E. Karagouni, M. Hatzistilianou, P. Boscolo, F. Ferro, M. Di Giannantonio, C.M.V. Conti, D. Merlitti R. Doyle, C. Petrarca, M.L. Castellani and T.C. Theoharides. 2004. Cytokines and the brain. Int. J. Immunopathol. Pharmacol. 17:229.
7. Diaco M., F. Ancarani, M. Montalto, E. Verrecchia, A. Evoli, S. Servidei, G. Gasbarrini and R. Manna. 2004. Association of myasthenia gravis and antisynthetase syndrome: a case report. Int. J. Immunopathol. Pharmacol. 17:395.
8. Marchisio M., G.M. Sabatino, A. Albanese, E. Santavenere, R. Buonaguidi and S. Miscia. 2004. Novel evidence of PLC d2 involvement in the regulation of the differential evolution of human aneurysms. Int. J. Immunopathol. Pharmacol. 17:381.
9. Peene I., L . De Rycke, D. Baeten, I. Hoffman, E.M. Veys and F. De Keyser. 2004. History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 17:107.
10. Franchi C., G. Cainelli, E. Frigerio, C. Garutti and G.F. Altomare. 2004. Association of Cyclosporine and 311 nm UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach. Int. J. Immunopathol. Pharmacol. 17:401.
11. Mastrangelo F., M. Piccirilli, M. Dolci, S. Teté, L. Speranza, A. Patruno, F. Gizzi, M. Felaco, L. Artese and M.A. De Lutiis. 2005. Vascular endothelial growth factor (VEGF) in human tooth germ center. Int. J. Immunopathol. Pharmacol. 18:587.
12. Kalogeromitros D., D. Kempuraj, A. Katsarou-Katsari, S. Gregoriou, M. Makris, W. Boucher and T.C. Theoharides. 2005. Theophylline as "add-on" therapy in patients with delayed pressure urticaria: a prospective self-controlled study. Int. J. Immunopathol. Pharmacol. 18:595.
13. Dillon S.R., C. Sprecher, A. Hammond, et al. 2004. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5:752.
14. Dreuw A., S. Radtke, S. Pflanz, et al. 2004. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 279:36112.
15. Matalon R., S. Surendran, J.D. McDonald, A.O. Okorodudu, S.K. Tyring, K. Michals-Matalon and P. Harris. 2005. Abnormal expression of genes associated with development and inflammation Int. J. Immunopathol. Pharmacol. 18:557.
16. Liu Q. and M. R. Hamblin. 2005. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state Int. J. Immunopathol. Pharmacol. 18:391.
17. Ottonello L., M. Bertolotto, F. Montecucco, P. Dapino and F. Dallegri. 2005. Dexamethasone - induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathways Int. J. Immunopathol. Pharmacol. 18:403.
18. Cross M.L. 2004. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 17:127
19. Marinova S., P. Nenkov, R. Markova, S. Nikolaeva, R. Kostadinova, I. Mitov and M. Vretenarska. 2005. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol. 18:457.
20. Moseley T.A., D.R. Haudenschild, L. Rose and AH. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14:155.
21. Montalto M., L. Santoro, M. Vastola, V. Curigliano, R. Ricci, F.M. Vecchio, R. Manna and G. Gasbarrini. 2005. Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment. Int. J. Immunopathol. Pharmacol. 18:603.
22. Esposito I., F. Perna, A. Ponticiello, M. Perrella, M. Gilli and A. Sanduzzi. 2005. Natural killer cells in baland peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int. J. Immunopathol. Pharmacol. 18:541.
23. Gorbunov N.V., S.J. McFaul, A. Januszkiewicz and J.L. Atkins. 2005. Pro-inflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma. Int. J. Immunopathol. Pharmacol. 18:547.
24. Ballerini P., R. Ciccarelli, F. Caciagli, M.P. Rathbone, E.S. Werstiuk, U. Traversa, S. Buccella, P. Giuliani, S. Jiang, E. Nargi, D. Visini, C. Santavenere and P. Di Iorio. 2005. P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes Int. J. Immunopathol. Pharmacol. 18:417.
25. D'Haene N., C. Maris, F. Sandras, M.-F. Dehou, M. Remmelink, C. Decaestecker and I. Salmon. 2005. The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas Int. J. Immunopathol. Pharmacol. 18:431.
26. Bonsi L., L. Pierdomenico, M. Biscardi, C. Marchionni, S. Gavazzi,V. Fossati, B.Ghinassi, F. Alviano, D. Rondelli, M. Franchina, G.P. Bagnara and A. Grossi. 2005. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathway Int. J. Immunopathol. Pharmacol. 18:445.
27. Cavalieri B., M. Mosca, P. Ramadori, M.-G. Perrelli, L. De Simone, F. Colotta, R. Bertini, G. Poli and J.C. Cutrìn. 2005. Neutrophil recruitment in the reperfused-injured rat liver was effectively attenuated by repertaxin, a novelallosteric noncompetitive inhibitor of CXCL8 receptors: a therapeutic approach for the treatment of post-ischemic hepatic syndromes Int. J. Immunopathol. Pharmacol. 18:475.
28. Petrarca C., S. Frydas, J. Donelan, W. Boucher, N. Papadopoulou, J. Cao, M.L. Castellani, P. Conti, E. Toniato, I. Robuffo, J. Vecchiet, T. Iezzi, B. Madhappan and D. Kempuraj. 2005. Interleukin 27 (IL-27): a novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int. J. Immunopathol. Pharmacol. 18:191.
29. Appert-Collin A., F.H.T. Duong, P. Passilly DeGrace, A. Bennasroune, P. Poindron, J-M. Warter and J.P. Gies. 2005. Xaliproden (SR57746A) induces 5-HT1A receptors-mediated Map kinase activation in PC12 cells. Int. J. Immunopathol. Pharmacol. 18:233.
30. Brunetti L., C. Di Nisio, G. Orlando, C. Ferrante and M. Vacca. 2005. The regulation of feeding: a cross talk between peripheral and central signalling. Int. J. Immunopathol. Pharmacol. 18:201.
31. Trubiani O., R. Di Primio, T. Traini, J. Pizzicannella, A. Scarano, A. Piattelli and S. Caputi. 2005. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament. Int. J. Immunopathol. Pharmacol. 18:213.
32. Riccioni G., V. Di Pietro, T. Staniscia, L. De Feudis, G. Traisci, F. Capani, G. Ferrara, E. Di Ilio, G. Di Tano and N. D'Orazio. 2005. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. Int. J. Immunopathol. Pharmacol. 18:575.
33. Martini F., C. Agrati, G. D'Offizi and F. Poccia. 2005. HLA-E Up-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol. 18:26925.
34. Alexandrakis M.G., F.H. Passam, C.A. Pappa, J. Damilakis, G. Tsirakis, E. Kandidaki, E.N. Stathopoulos and D.S. Kyriakou. 2005. Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density. Int. J. Immunopathol. Pharmacol. 18:287.
35. Fioriti D., A.M. Degener, M. Mischitelli, M. Videtta, A. Arancio, S. Sica, F. Sorà and V. Pietropaolo. 2005. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant. Int. J. Immunopathol. Pharmacol. 18:309.
36. Longhi C., M.P. Conte, S. Ranaldi, M. Penta, P. Valenti, A. Tinari, F. Superti and L. Seganti. 2005. Apoptotic death of listeria monocytogenes-infected human macrophages induced by lactoferricin B, a bovine lactoferrin-derived peptide. Int. J. Immunopathol. Pharmacol. 18:317.
37. Lesma E., E. Riva, M. Giovannini, A.M. Di Giulio and A. Gorio. 2005. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Int. J. Immunopathol. Pharmacol. 18:297.
38. neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in her-2/neu transgenic mice. Int. J. Immunopathol. Pharmacol. 18:351.
39. Rossi R.E. and G. Monasterolo. 2005. A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int. J. Immunopathol. Pharmacol. 18:277.